Correlation Between AN2 Therapeutics and Hillstream Biopharma
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Hillstream Biopharma, you can compare the effects of market volatilities on AN2 Therapeutics and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Hillstream Biopharma.
Diversification Opportunities for AN2 Therapeutics and Hillstream Biopharma
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between AN2 and Hillstream is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Hillstream Biopharma go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Hillstream Biopharma
Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the Hillstream Biopharma. In addition to that, AN2 Therapeutics is 1.31 times more volatile than Hillstream Biopharma. It trades about -0.01 of its total potential returns per unit of risk. Hillstream Biopharma is currently generating about 0.08 per unit of volatility. If you would invest 36.00 in Hillstream Biopharma on September 1, 2024 and sell it today you would earn a total of 3.00 from holding Hillstream Biopharma or generate 8.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.06% |
| Values | Daily Returns |
AN2 Therapeutics vs. Hillstream Biopharma
Performance |
| Timeline |
| AN2 Therapeutics |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AN2 Therapeutics and Hillstream Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Hillstream Biopharma
The main advantage of trading using opposite AN2 Therapeutics and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |